NAVICAN GENOMICS AN INTERMOUNTAIN HEALTHCARE COMPANY
DEAD

Serial Number

87150199

Owner

Intermountain Insights, LLC

Attorney

Joshua G. Gigger

Filing Date

Aug 25, 2016

Add to watchlist:

No watchlists yet
View on USPTO

NAVICAN GENOMICS AN INTERMOUNTAIN HEALTHCARE COMPANY Trademark

Serial Number: 87150199

NAVICAN GENOMICS AN INTERMOUNTAIN HEALTHCARE COMPANY is a trademark filed by Intermountain Insights, LLC on August 25, 2016. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Intermountain Insights, LLC (5 trademarks)

36 South State Street, Suite 2200
Salt Lake City, UT 84111

Entity Type: 16

Trademark Details

Filing Date

August 25, 2016

Registration Date

Not Registered

Published for Opposition

November 1, 2016

Goods & Services

Medical diagnostic reagents and assays for testing of tumor tissue or body fluids

Pharmaceutical benefit management services; insurance claims processing in the field of diagnostics and pharmaceutical claims; providing a database featuring information and statistics about patient reimbursement and insurance coverage for diagnostics and pharmaceuticals; and reimbursement payment processing in the field of diagnostics and pharmaceutical claims; and providing information in the field of financial support options and resources for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing patient reimbursement and insurance coverage information in the field of diagnostics reimbursement for providers and patients; financial administration of diagnostics and pharmacy reimbursement programs and services

Pharmaceutical procurement services, namely, purchasing pharmaceuticals for others; pharmaceutical cost management services and drug utilization review services; assisting patients in enrolling in diagnostics and pharmaceutical reimbursement programs of others; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of drug reimbursement for prescribers, patients and the pharmaceutical industry; providing business, pricing, reimbursement benchmarking and other market intelligence information in the field of diagnostics reimbursement for providers and patients; business administration of diagnostics and pharmacy reimbursement programs and services; business management and consultation services in the field of specialty pharmacy, namely, assisting patients and providers with pharmaceutical reimbursement; business management and consultation services in the field of off label pharmaceuticals, namely, assisting patients and providers with pharmaceutical reimbursement; business management services in the field of diagnostics, namely, assisting patients and providers with diagnostics reimbursement; and promoting collaboration within the scientific, research and medical communities to achieve advances in the fields of healthcare and pharmaceuticals; business management of comprehensive programs involving drug therapy

Assays and reagents for use in genetic research

Dispensing of pharmaceuticals; medical and pharmaceutical consultation; pharmaceutical advice; pharmaceutical compounding services; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis, treatment and prevention purposes; providing genetic sequencing and consulting services via website designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians via a website to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services via a website, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive treatment programs involving drug therapy; physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancers; providing medical evaluations of patients to determine acceptability for participation in clinical trials; providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of oncology; providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions; providing an online searchable database in the fields of oncolology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for personalized diagnosis, treatment and prevention of cancer

Medical, clinical and scientific research in the field of oncology, namely, research relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; scientific and technological services, namely, research services for medical purposes in the field of genetic diagnostic assays and pharmaceuticals research for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information and scientific consulting in the field of genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; conducting early evaluations in the field of new genetic diagnostics assays and pharmaceuticals; development, evaluation and medical and scientific research of genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; laboratory research services relating to genetic diagnostic assays for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals, clinical trials and genetics; technical consulting related to scientific and medical studies in the field of genetic diagnostic assay and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; basic and clinical research in the field of oncology, namely, researching genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; providing medical and scientific research information in the field of genetic diagnostic assays, pharmaceuticals and clinical trials for personalized diagnosis, treatment and prevention of cancer; custom design and development of chemical reagants and multiplex sequencing assays for personalized diagnosis, treatment and prevention of cancer; providing an on-line computer database featuring medical and scientific research information in the field of oncology that allows for input and collection of scientific and research data and information relating to genetic diagnostic assays and pharmaceuticals for diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies relating to genetic diagnostic assays and pharmaceuticals for personalized diagnosis, treatment and prevention of cancer; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments for personalized diagnosis, treatment and prevention of cancer; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies for personalized diagnosis, treatment and prevention of cancer; providing a website featuring technology with a web-based interface where medical professionals can view genetic test results and interpretations of the results by scientists and medical professionals in the field of genomics, and select the appropriate treatment and order the necessary pharmaceutical products

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jul 31, 2017 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Jul 31, 2017 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 27, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 1, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 1, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 12, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 27, 2016 PREV
ASSIGNED TO LIE
Sep 27, 2016 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 14, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 14, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 14, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 14, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 14, 2016 CNEA
ASSIGNED TO EXAMINER
Sep 8, 2016 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 31, 2016 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2016 NWOS
NEW APPLICATION ENTERED
Aug 29, 2016 NWAP